These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 1545040
1. Fluoxetine: no association with suicidality in obsessive-compulsive disorder. Beasley CM, Potvin JH, Masica DN, Wheadon DE, Dornseif BE, Genduso LA. J Affect Disord; 1992 Jan; 24(1):1-10. PubMed ID: 1545040 [Abstract] [Full Text] [Related]
2. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. Beasley CM, Dornseif BE, Bosomworth JC, Sayler ME, Rampey AH, Heiligenstein JH, Thompson VL, Murphy DJ, Masica DN. BMJ; 1991 Sep 21; 303(6804):685-92. PubMed ID: 1833012 [Abstract] [Full Text] [Related]
3. Lack of association between fluoxetine and suicidality in bulimia nervosa. Wheadon DE, Rampey AH, Thompson VL, Potvin JH, Masica DN, Beasley CM. J Clin Psychiatry; 1992 Jul 21; 53(7):235-41. PubMed ID: 1639742 [Abstract] [Full Text] [Related]
4. Evaluation of suicidality during pharmacologic treatment of mood and nonmood disorders. Tollefson GD, Fawcett J, Winokur G, Beasley CM, Potvin JH, Faries DE, Rampey AH, Sayler ME. Ann Clin Psychiatry; 1993 Dec 21; 5(4):209-24. PubMed ID: 8312978 [Abstract] [Full Text] [Related]
10. Pharmacotherapy of obsessive compulsive disorder--experience with fluoxetine. Wood A, Tollefson GD, Birkett M. Int Clin Psychopharmacol; 1993 Aug 21; 8(4):301-6. PubMed ID: 8277151 [Abstract] [Full Text] [Related]
11. Suicidal behavior in obsessive-compulsive disorder. Kamath P, Reddy YC, Kandavel T. J Clin Psychiatry; 2007 Nov 21; 68(11):1741-50. PubMed ID: 18052568 [Abstract] [Full Text] [Related]
12. Fluoxetine and adult suicidality revisited: an updated meta-analysis using expanded data sources from placebo-controlled trials. Beasley CM, Ball SG, Nilsson ME, Polzer J, Tauscher-Wisniewski S, Plewes J, Acharya N. J Clin Psychopharmacol; 2007 Dec 21; 27(6):682-6. PubMed ID: 18004137 [Abstract] [Full Text] [Related]
16. Suicidality in a placebo-controlled fluoxetine study of body dysmorphic disorder. Phillips KA, Kelly MM. Int Clin Psychopharmacol; 2009 Jan 21; 24(1):26-8. PubMed ID: 19060721 [Abstract] [Full Text] [Related]
17. A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group. Montgomery SA, McIntyre A, Osterheider M, Sarteschi P, Zitterl W, Zohar J, Birkett M, Wood AJ. Eur Neuropsychopharmacol; 1993 Jun 21; 3(2):143-52. PubMed ID: 8364350 [Abstract] [Full Text] [Related]
18. Long-term treatment of obsessive-compulsive disorder after an acute response: a comparison of fluoxetine versus placebo. Romano S, Goodman W, Tamura R, Gonzales J. J Clin Psychopharmacol; 2001 Feb 21; 21(1):46-52. PubMed ID: 11199947 [Abstract] [Full Text] [Related]